Hematology & Bone Marrow Transplantation
Hematology The Hematology Department provides services for the diagnosis and treatment of blood disorders and simultaneously runs the bone marrow transplantation services. The Hematology team consists of hematologists, nurses, technicians, nutritionists, and pharmacists who are experts in treating both benign and malignant blood disorders such as anemia, coagulation disorders, sickle cell anemia, leukemia, multiple myeloma, lymphoma, etc. The Hematology services work in close collaboration with the other departments such as radiation oncology, nuclear medicine, pathology, and infectious diseases to ensure that treatment decisions are based on multi-disciplinary discussions in the weekly tumor board and hemato-pathology board.
The department is supported by a apheresis unit, blood bank, and a fully equipped laboratory with the latest generation flow cytometry, molecular and genetic techniques.
BMT
The Bone Marrow and Stem Cell Transplant Unit at Bahrain Oncology Center is the only center in Bahrain that carries out the treatment of patients in need of allogeneic and autologous stem cell transplantation. Our transplantation program has consultants, senior registrars, clinical pharmacists, apheresis managers and nurses with more than 10 years of experience in the field.
Our ten-bed unit is equipped with state-of-the-art equipment and is supported by an outpatient department that conducts pre- and post-transplant follow up.
Bone marrow/ stem cell transplantation is a procedure to replace damaged or cancerous bone marrow with healthy stem cells; a procedure that can help revamp the blood and the immune system through autologous or allogeneic transplantation.
Autologous transplantation a high dosage chemotherapy procedure in which the patient’s own stem cells are collected and stored. After the patient has been treated with high dose chemotherapy, the stem cells are intravenously infused back to the patient.
Allogenic transplantation a procedure where the stem cells are collected from a healthy donor like siblings, relatives, or unrelated donors and intravenously infused to the patient after treatment with chemo-radiation.
The Bone Marrow and Stem Cell Transplant Center at Bahrain Oncology Center has successfully completed the accreditation for CASGEVY, a new cell-based gene therapy. CASGEVY is approved for treating sickle cell disease and beta thalassemia. It's the first FDA-approved therapy that uses CRISPR/Cas9, a cutting-edge genome editing technology. In this therapy, the patient’s blood stem cells are edited using CRISPR/Cas9 to correct the genetic defects causing the disease.
A project initiated by the Crown Prince and Prime Minister his Royal Highness Salman bin Hamad bin Isa Al Khalifa.
Other Specialities
Medical Oncology
Medical Oncology is a discipline that is concerned with every stage of treatment; from screening and early diagnosis, to care and treatment of oncology patients.
Day Case Unit
Drug treatments for cancer is often delivered on a day case outpatient basisPatients come to the hospital, their medical tests are checked, potential risks of toxicity are assessed and treatment is delivered.
Cell Therapy Unit (Apheresis Unit)
The Apheresis Unit at the Bahrain Oncology Center opened in 2020. It offers various treatments, with plasma exchange transfusions making up 61% of the procedures and collecting a patient’s own stem cells for future use accounting for 32%.
Book an Appointment
Our expert teams are ready to support you on your health journey. Contact us today to discover how we can help you achieve and maintain your well-being.
Book AppointmentYour Health, Just a Tap Away!
Download the RMS Hospital Mobile App for easy appointments, medical records access, and personalized care anytime, anywhere.
